Trade DRMAW stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Dermata Therapeutics Inc Warrant (DRMAW) is trading at US$0.00, up 0.00% today as of Sep 9, 16:00 EDT. Over the past 52 weeks, DRMAW has traded between US$0.00 and US$0.03. On Syfe you can trade DRMAW with $0 commission and add it to your watchlist.
| Previous close | US$0.00 |
|---|---|
| 52-week range | US$0.00 – US$0.03 |
| Volume | 146.06K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Dermata Therapeutics Inc Warrant
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
Year: 2021
Dermata Therapeutics Inc Warrant (DRMAW) stock is trading at US$0.00, 0.00% from the previous close of US$0.00.
The 52-week high for Dermata Therapeutics Inc Warrant (DRMAW) stock is US$0.03.
The 52-week low for Dermata Therapeutics Inc Warrant (DRMAW) stock is US$0.00.
Dermata Therapeutics Inc Warrant (DRMAW) does not currently pay a dividend.
Stay on top of DRMAW
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
